# Detection of Circulating Biomarkers of Immunogenic Cell Death

> **NCT02921854** · NA · COMPLETED · sponsor: **Maastricht Radiation Oncology** · enrollment: 60 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **OTHER:** Blood withdrawal

## Key facts

- **NCT ID:** NCT02921854
- **Lead sponsor:** Maastricht Radiation Oncology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-04
- **Primary completion:** 2019-06-19
- **Final completion:** 2019-06-19
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02921854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02921854, "Detection of Circulating Biomarkers of Immunogenic Cell Death". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT02921854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*